Abstract
Amiodarone is an iodine rich agent widely used for the treatment of ventricular arrhythmias, paroxysmal supraventricular tachycardia, atrial fibrillation and flutter. However 14-18% of patients treated with amiodarone develop overt thyroid dysfunction in the form of either amiodarone-induced thyrotoxicosis (AIT) or amiodaroneinduced hypothyroidism (AIH). Two different types of AIT have been recognised and designated as Type 1 and Type 2. Distinguishing between the two is often difficult, but necessary for instituting appropriate treatment. We report a case of a 56 year-old male patient who was started on amiodarone for atrial fibrillation and then developed AIT. The challenges in the diagnosis and management of these patients are discussed.
Publication Date
12-19-2009
First Page
319
Last Page
323
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
PS, Sudheer Ahamed and Mathew, Abe
(2009)
"A Case of Amiodarone-Induced Thyrotoxicosis : A diagnostic and therapeutic dilemma,"
Sultan Qaboos University Medical Journal: Vol. 9: 319-323.
DOI: https://doi.org/10.18295/2075-0528.2808
